Propensity‐Matched Five‐Year Cardiac Resynchronization Therapy Outcomes in Sarcoidosis With Heart Failure
CRT implantation had similar long-term outcomes compared to ICD-only implantation in patients with sarcoidosis and HFrEF, particularly all-cause mortality, all-cause hospitalization, heart failure exacerbation, and the proportion of patients with improvement in LVEF to greater than 40% and greater than 50%.
Authors
- Abhishek Deshmukh (ORCID: https://orcid.org/0000-0002-9560-1102)
- Christopher V. DeSimone (ORCID: https://orcid.org/0000-0002-8420-4670)
- Hicham El Masry (ORCID: https://orcid.org/0000-0002-2470-2862)
- Min Choon Tan (ORCID: https://orcid.org/0000-0002-7682-8934)
- Dan Sorajja (ORCID: https://orcid.org/0000-0003-1976-6420)
- Luis R. Scott (ORCID: https://orcid.org/0000-0002-1010-1062)
- Justin Z. Lee (ORCID: https://orcid.org/0000-0003-2823-9243)
- Yong Hao Yeo (ORCID: https://orcid.org/0000-0001-5559-7236)
- Tze Ern Ong (ORCID: https://orcid.org/0009-0009-4200-3983)
- Aravinthan Vignarajah (ORCID: https://orcid.org/0000-0002-3758-0024)
- Nishanthi Vigneswaramoorthy
Institutions
- Cleveland Clinic (US)
- Mayo Clinic (US)
- SUNY Upstate Medical University (US)
- Interfaith Medical Center (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Beaumont Hospital, Royal Oak (US)
- Mayo Clinic in Florida (US)
- Saint Michael's Medical Center (US)
- Beaumont Hospital, Troy (US)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1111/jce.70204
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00